The Contribution Made by Jeanmarie Guenot and Amphivena Therapeutics Inc. in the U.S. Healthcare and Pharmaceutical Sectors

Jeanmarie Guenot is presently the President of Amphivena Therapeutics, a healthcare company in San Francisco, California. She has gained a lot of experience in her 20-year career working in the pharmaceutical and biotechnology industries. Amphivena Therapeutics specializes in developing immune therapies for cancer treatment. Amphivena Therapeutics is a subsidiary of Affirmed Therapeutics AG, which was established in 2012 and its headquarters are located in San Francisco.

 

Since its formation, the company has been leading in the development of remedy antibodies for blood cancer treatment, which is Jeanmarie’s passion. The intention of the therapeutic antibodies is to enhance the patient’s natural immune system to generate antibodies that can unite to focus on the molecules on tumor cells and destroy them.

 

Amphivena Therapeutics is a privately-owned company. The firm’s parent company, Affimed Therapeutics AG as well as MPM Capital and Aeris Capital are some of the institutional investors that contributed to its first funding round. Jeanmarie strikes up new and mutually beneficial partnerships with other industry stakeholders to ensure the continuity of Amphivena Therapeutics’ research projects.

 

The Career of Jeanmarie Guenot

 

Guenot was accredited her MBA from the University of Pennsylvania and later graduated with a Ph.D. from the University of California. Her career took off right after getting her Ph.D. She worked as the chief scientist in Preclinical R&D at Hoffman-La Roche.

 

Jeanmarie heads Amphivena Therapeutics Inc. as President. Her duties also include project management, commercial development, venture capital, R&D. She provides consultation services for licensing, M&A, project management, and financial planning. For pharmaceutical and biotech companies, she offers alliance and finance management services.

 

Jeanmarie Guenot has pioneered a successful contract between Hoffmann- La Roche and PDL. The deal will see the collaboration of the two companies in commercializing and developing their drugs. Today, Jeanmarie is involved in numerous studies and research projects aimed at coming up with medical breakthroughs that will help patients not only in the United States but also globally.

Leave a Reply

Your email address will not be published. Required fields are marked *